If you typed Idea Médica into a search box, you are probably building a CRO shortlist. This article uses only what Idea Médica publishes (ideamedica.com.ar) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.
What Idea Médica publishes
Idea Médica describes itself as an Argentine holding of healthcare companies founded by physicians more than 30 years ago. It designs and runs turnkey critical medical services for clinics, sanatoriums and hospitals (clinical cardiology, hemodynamics, electrophysiology, nuclear medicine and echocardiography), and also offers strategic communication and medical training. Its scientific research service coordinates clinical trials across medical institutions and links them with the pharmaceutical and biotechnology industry: protocol design and ethics approval, patient recruitment and follow-up, operational coordination and monitoring, and data management and reporting. Its homepage features cardiologist Dr. Álvaro Sosa Liprandi, a former president of the Argentine Society of Cardiology. The current site does not mention medical-device trials.
Idea Médica vs bioaccess®
| Dimension | Idea Médica | bioaccess® |
|---|---|---|
| Core focus | Argentine cardiology-services holding that coordinates clinical trials | First-in-human and early feasibility studies for medical devices |
| Geography | Argentina (institutions across the country, per its homepage) | Latin America, since 2010 |
| Device FIH track record | No named device first-in-human study found on the public pages reviewed | Published case studies on bioaccessla.com |
| After the trial | See provider site | Live multi-country sanitary registration and in-country holder service |
Where each one fits
If you need an Argentine partner that coordinates trials across the cardiology services it manages, Idea Médica is worth a call as a site-side partner.
If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO on your list, including Idea Médica, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.
Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.
Ready to compare a proposal? Request a first-in-human study proposal.
Competitor facts from the Idea Médica public pages linked above and public announcements, reviewed for bioaccess® competitive research (Aug 2026–Nov 2026). Claims are theirs. No invented sponsors, prices or contacts.